Abstract
The transmembrane glycoprotein, CUB (complement C1r/C1s, Uegf, Bmp1) domain-containing protein 1 (CDCP1) is overexpressed in several cancer types and is a predictor of poor prognosis for patients on standard of care therapies. Phosphorylation of CDCP1 tyrosine sites is induced upon loss of cell adhesion and is thought to be linked to metastatic potential of tumor cells. Using a tyrosine-phosphoproteomics screening approach, we characterized the phosphorylation state of CDCP1 across a panel of breast cancer cell lines. We focused on two phospho-tyrosine pTyr peptides of CDCP1, containing Tyr707 and Tyr806, which were identified in all six lines, with the human epidermal growth factor 2-positive HCC1954 cells showing a particularly high phosphorylation level. Pharmacological modulation of tyrosine phosphorylation indicated that, the Src family kinases (SFKs) were found to phosphorylate CDCP1 at Tyr707 and Tyr806 and play a critical role in CDCP1 activity. We demonstrated that CDCP1 overexpression in HEK293 cells increases global phosphotyrosine content, promotes anchorage-independent cell growth and activates several SFK members. Conversely, CDCP1 downregulation in multiple solid cancer cell lines decreased both cell growth and S...Continue Reading
References
Apr 25, 2000·Molecular and Cellular Biology·G ManesS Roche
Apr 2, 2003·The Journal of Biological Chemistry·Rakesh VermaLawrence B Holzman
Jan 24, 2004·The Journal of Biological Chemistry·Tod A BrownWilliam G Carter
Apr 27, 2005·Cell·Cyril H BenesStephen P Soltoff
Jul 11, 2006·The Journal of Pathology·J-i IkedaK Aozasa
May 17, 2008·Cancer Research·Amara C SivaHong Xin
May 24, 2008·Molecular Cell·Chitose OneyamaMasato Okada
Dec 17, 2008·Cancer Science·Jun-ichiro IkedaEiichi Morii
Mar 12, 2009·Cancer Research·Cédric LeroySerge Roche
Mar 18, 2009·Immunological Reviews·Robert J SalmondRose Zamoyska
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ching Hang WongMark M Moasser
Jun 11, 2009·IUBMB Life·Andreas WortmannJohn D Hooper
Sep 30, 2009·Nature Reviews. Clinical Oncology·Lori C KimEric B Haura
Dec 17, 2009·Oncogene·A SirventS Roche
May 27, 2010·Cancer Research·Yuri MiyazawaRyuichi Sakai
Sep 24, 2010·Cancer Research·Falko HochgräfeRoger J Daly
Jan 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Hui LiuRichard O Hynes
Jan 15, 2011·Proceedings of the National Academy of Sciences of the United States of America·Olga V RazorenovaAmato J Giaccia
Aug 5, 2011·Cancer Science·Takamasa Uekita, Ryuichi Sakai
Dec 5, 2012·Oncogene·B CasarE I Deryugina
Jul 23, 2013·Cancer Research·Abdullah AlajatiMohamed Bentires-Alj
Jan 25, 2014·Nature Communications·Cécile NaudinSerge Roche
Citations
Feb 18, 2016·British Journal of Cancer·Brittney S HarringtonJohn D Hooper
Feb 16, 2016·Oncogene·H J WrightO V Razorenova
May 2, 2017·PLoS Computational Biology·Ying LiTingting Li
Jan 24, 2018·ELife·Alexander J MartinkoJames A Wells
Sep 20, 2017·Oncogene·M PeregoM Herlyn
Aug 19, 2017·Molecular Cancer·Zheng FangYongxiang Li
May 25, 2018·BMC Cancer·Luca ForteFrancesca Bianchi
Jan 15, 2020·BMC Cancer·Xia LiaoQingan Jia
Jul 16, 2019·Experimental Cell Research·Danilo PredesFabio A Mendes
Dec 18, 2019·The American Journal of Pathology·Luke J NelsonF Scott Heinemann
Feb 13, 2021·Life Science Alliance·Kentaro KajiwaraMasato Okada
Oct 14, 2019·Archives of Biochemistry and Biophysics·Zheng WuLiang Yuan